Previous studies have suggested that measurement of plasma bicarbonate concentration using the Henderson-Hasselbalch equation may be unreliable, particularly in critically ill patients. We examined the agreement between two plasma bicarbonate concentration assays in critically ill patients. Data were collected from records of routine daily blood samples. Paired samples were taken at the same time from arterial lines. A Bland-Altman analysis was used to compare two bicarbonate assays in clinical use. The first used the Henderson-Hasselbalch equation for blood-gas machine calculations. The second used a spectrophotometric enzymatic technique. Comparing the enzymatic method to the calculated method (enzymatic minus calculated) the bias was -1.6 mmol/l (95% CI: -1.2 to -2.0 mmol/l). The limits of agreement were -5.85 mmol/l to 2.65 mmol/l. This study found poor agreement between the two bicarbonate assays. This poor agreement is clinically important but the causes are unclear. We suggest further investigation of the reliability of bicarbonate assays.
In the past, the reliability of assays of plasma bicarbonate concentration using the Henderson-Hasselbalch equation (Figure 1 ) has been questioned. Of particular concern have been assays of samples from critically ill patients 1 . Previous studies used statistical techniques now thought to be unreliable or asking the wrong question 2 . We asked, using a Bland-Altman analysis, what is the agreement between two plasma bicarbonate concentration assays used in the management of critically ill patients? pH=pKa+[HCO 3 -] α PCO 2
METHODS
Data were prospectively collected from intensive care unit records at the Austin and Repatriation Medical Centre, a tertiary referral hospital. All samples were routine morning samples taken from arterial lines in patients requiring intensive care management. No additional sampling was required and collected data did not identify individual patients. The Austin and Repatriation Medical Centre Human Research Ethics Committee waived the need for informed consent.
Arterial blood samples were collected in heparinized blood gas syringes (Rapidlyte, Chiron Diagnostics, East Walpole, MA, U.S.A.) and analysed in the intensive care unit blood gas analyser (Ciba Corning 865, Ciba Corning Diagnostics, Medfield, MA, U.S.A.). The analyser software calculated plasma bicarbonate with the Henderson-Hasselbalch equation (Figure 1 ) from the measured pH and partial pressure of carbon dioxide at 37°C. Analysis was performed by nursing staff from the intensive care unit who had been taught to use the machine by support staff. Samples were not stored on ice. Using a Monte Carlo approach, we estimated the likely variability for the calculated bicarbonate due to measurement variability for pH and the partial pressure of carbon dioxide. From the manufacturer's manual we used a standard deviation of 0.004 pH units for the pH and 1.2 mmHg for the partial pressure of carbon dioxide. The carbon dioxide solubility coefficient was 0.0307. The apparent overall dissociation constant for carbonic acid was 6.105.
For each data pair, samples were drawn at the same time from the same arterial sampling point using a vacuum technique with lithium heparin tubes (Vacuette, Greiner labortechnik, Kremsmunster, Austria). These samples were sent to the hospital core laboratory in the Division of Laboratory Medicine. As part of a multicomponent analysis, plasma bicarbonate concentration was measured by an automated spectrophotometric enzymatic technique 3 ( Figure 2 ) at 37°C (Hitachi 747, Roche Diagnostics, Sydney, N.S.W.). Samples were analysed by scientific staff from the hospital clinical chemistry department. Samples were not stored on ice.
Agreement between the two assays was assessed using a Bland-Altman analysis 2 . After reviewing clinical use of plasma bicarbonate concentrations 4,5 , we proposed that bias greater than ±1 mmol/l and limits of agreement wider than bias ±2 mmol/l, a total span of 4 mmol/l, were clinically important. We proposed to collect 100 pairs of data.
RESULTS
A total of 102 pairs of data were collected over several weeks. Data collection was limited by sample pairs not being drawn at the same time. Comparing the enzymatic method to the calculated method (enzymatic minus calculated) the bias was -1.6 mmol/l (95% CI: -1.2 mmol/l to -2.0 mmol/l). The standard deviation of the difference was 2.17 mmol/l. The limits of agreement were defined as the bias ±1.96 x standard deviation of the difference. The limits of agreement were -1.6 mmol/l ±4.25 mmol/l. The upper limit of agreement was 2.65 mmol/l (95%CI: 2.28 mmol/l to 3.02 mmol/l). The lower limit of agreement was -5.85mmol/l (95%CI: -6.22 mmol/l to -5.48 mmol/l). At best, the limits of agreement spanned 7.76 mmol/l. At worst, the limits of agreement spanned 9.24 mmol/l. The Bland-Altman plot of average bicarbonate concentration versus the difference between the two assays is shown in Figure 3 .
From the Monte Carlo simulation the estimated standard deviation for the calculated bicarbonate concentration was 1.02 mmol/l.
DISCUSSION
Estimation of plasma bicarbonate concentration is an important part of diagnosis and management of critically ill patients. Both the "Boston" and "Copenhagen" approaches to acid-base assessment use plasma bicarbonate concentration. The "Boston" approach uses plasma bicarbonate directly 6 . The "Copenhagen" approach requires the calculation of plasma bicarbonate to calculate base excess 7 . Using samples from critically ill patients, we found poor agreement between two plasma bicarbonate assays. We cannot, however, determine the cause or causes of the poor agreement.
In separate reviews of acid-base disorders, Worthley 4 and Abelow 5 use a "Boston" type approach for assessing metabolic compensation for respiratory acidosis. In the acute situation, they both suggest that for each 10 mmHg rise in carbon dioxide partial pressure we would expect a 1 mmol/l rise in plasma bicarbonate concentration. We found that, compared to the enzymatic method, the calculated result is likely to be 1.6 mmol/l higher but maybe up to 5.85 mmol/l higher or up to 2.65 mmol/l lower. This poor agreement suggests that the data for determining metabolic compensation could be inaccurate. Other calculations that require a value for plasma bicarbonate concentration including base excess 7 and anion gap 4 could also be inaccurate.
Research groups have debated the reliability of 400 Average HCO 3by two methods, mmol/l plasma bicarbonate assays using the Henderson-Hasselbalch equation, particularly in critically ill patients. Blood gas machine software uses the Henderson-Hasselbalch equation to calculate bicarbonate concentration. Bicarbonate forms about 95% of total blood carbon dioxide content. Because of the close relationship, bicarbonate concentration and total carbon dioxide content have been used interchangeably in clinical use 8 . The research groups compared total carbon dioxide, calculated from measured pH and partial pressure of carbon dioxide, and directly measured total carbon dioxide. From their findings some argued that the constants used for the apparent, overall dissociation constant of carbonic acid (pKa) and the solubility of carbon dioxide were not sufficiently consistent in clinically unstable patients to reliably use the Henderson-Hasselbalch equation 1, 9, 10 . This argument has been vigorously rejected by those who found more consistent values for these constants 7, [11] [12] [13] .
In many clinical settings the older and technically difficult procedure of total carbon dioxide content or bicarbonate concentration assay from carbon dioxide gas has been replaced by other techniques. At our medical centre bicarbonate is measured as part of an automated clinical chemistry screen. The assay uses a spectrophotometric enzymatic technique (Figure 2) 3 . The manufacturer describes this assay as a bicarbonate assay although it is a total carbon dioxide assay because all carbon dioxide is converted to bicarbonate. The reason this can be described as a bicarbonate assay is that under clinical conditions, dissolved carbon dioxide gas is lost to the atmosphere at a rate of about 6 mmol/h during processing. After processing, the measured total carbon dioxide concentration is closer to the initial bicarbonate concentration than the initial total carbon dioxide content 8 .
Our study is the first to examine the agreement between different bicarbonate, or total carbon dioxide, assays using the Bland-Altman approach 2 . This approach is now the most widely used to study the agreement between methods of measurement 14 . A variety of statistical techniques were used in the past to study the agreement between calculated and directly measured total carbon dioxide. Some used correlation 1, 9, 10, 13 . Bland and Altman 15 argue that correlation asks if there is a relationship between two measurement techniques rather than the nature of agreement. They suggest where two techniques are measuring the same parameter a significant correlation is likely. Therefore, in the older studies, comparing a Henderson-Hasselbalch approach and direct measurement of total carbon dioxide, it is not surprising that several found good correlation. Further, good correlation can occur in the presence of poor agreement; for example where A is always exactly twice B. Some used regression analysis 1, 11, 13 . Bland and Altman 15 argue that regression analysis is not appropriate because it asks the question, how do we calculate A from B and B from A?, rather than, what is the agreement? Other studies used t-tests to compare differences in the mean value of bicarbonate or carbon dioxide 1, 13, 16 . Bland and Altman 15 argue that t-tests can be used to detect bias (consistent error) but will not demonstrate wide limits of agreement: the 95% confidence interval for the difference between the two methods for an individual sample pair. If the variances of the samples or differences are wide, t-tests are less likely to detect underlying bias. That is, recognition of poor agreement is less likely. We believe that our study is the first to examine bicarbonate assays in a manner likely to detect poor agreement.
Our study revealed two aspects of poor agreement between the enzymatic and calculated techniques. First, there was significant bias and second there were wide limits of agreement. From the bias, the calculated bicarbonate concentration was greater than the total carbon dioxide content. We expected the opposite. This finding suggests that clinically important amounts of carbon dioxide are lost during processing for the enzymatic assay. Given that processing times are not identical, the loss of carbon dioxide will vary and will be one cause of the wide limits of agreement. Transfer of the samples from lithium heparin tubes to secondary analysis tubes will aggravate the loss of carbon dioxide. The duration of exposure to the atmosphere was not standardized. The blood to gas ratio in the lithium heparin tubes was set by the vacuum method used for collection. The combined effects of time to analysis, exposure to the atmosphere, and the samples not being on ice is difficult to quantify.
Other causes for wide limits of agreement from one or both assays include calibration errors, poor sample handling and processing, as well as inconsistent constants for software calculations due to the pathophysiology of critically ill patients. The apparent overall dissociation constant for carbonic acid will change with temperature. In our study however, both methods were performed at 37°C. The blood-gas machine did not correct the apparent overall dissociation constant for carbonic acid for pH changes due to carbamate and carbonate; this however, is a minor effect 17 . The Monte Carlo analysis indicates that the combined variability in the pH and carbon dioxide partial pressure measurements is likely to be one source of poor agreement. The standard deviation of the plasma bicarbonate was less than half the standard deviation of the precision of the Bland-Altman analysis. This difference suggests other factors are likely to be involved. Our study demonstrates the poor agreement between the two assays but does not allow us to draw firm conclusions about the causes.
We found poor agreement between two bicarbonate assays of samples from critically ill patients. Our findings suggest that clinically important errors are occurring in the calculated assay or the enzymatic assay or both. These findings cannot be extrapolated to other types and brands of measured and calculated bicarbonate assays. But, given the importance of plasma bicarbonate concentration assays in the management of critically ill patients, we believe the causes of the poor agreement need further investigation. We need to determine which bicarbonate assay is the most reliable and which assays are unacceptably unreliable.
